Zevra Therapeutics Change in Payables and Accrued Expense (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

9.08 +0.05 (+0.55%) USD | NASDAQ | Jan 22, 16:00

9.28 +0.20 (+2.20%) After-Hours: 04:30

View Change in Payables and Accrued Expense (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Change in Payables and Accrued Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Change in Payables and Accrued Expense (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	Upgrade
Verastem, Inc.	Upgrade
ADMA Biologics, Inc.	Upgrade
Akebia Therapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade